Gene Therapy for the Treatment of Infectious Diseases

Gene therapy confines considerable potential for the treatment of both infectious diseases and hereditary genetic disorders. Human gene therapy is defined as the presentation of new genetic material into the cells of a person with the purpose of generating a therapeutic advantage for the patient. Gene therapy is being researched as an alternative for a number of infectious diseases that does not agree to the standard clinical administration. Gene therapy for infectious diseases needs the introduction of genes outlined to particularly repress or block the gene expression or function of gene products, to such an extent that the replication of the infectious agent is blocked or constrained. In addition to this intracellular interference, gene therapy may be used to mediate in the spread of the infectious agent at the extracellular level. This could be accomplished by sustained expression in vivo of a discharged inhibitory protein or stimulation of a specific immune response.

  • Molecular therapy
  • Nucleic Acid-Based Genetic Therapy
  • Protein-Based Approaches to Gene Therapy
  • Immunotherapy
  • Target Pathogens for Antimicrobial Gene Therapy

Related Conference of Gene Therapy for the Treatment of Infectious Diseases

August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

Singapore
October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
November 05-06, 2020

9th Asia Pacific STD and Infectious Diseases Congress

Tokyo, Japan
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
February 22-23, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore

Gene Therapy for the Treatment of Infectious Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in